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PEMBANGUNAN NANO-FORMULASI PVP/P407 BERASASKAN SERAKAN 
PEPEJAL EKSTRAK ETANOL TERPIAWAI DAUN ORTHOSIPHON 
STAMINEUS UNTUK PENAMBAHBAIKAN KETERLARUTAN DAN 
BIOPEROLEHAN ORAL 
 
 ABSTRAK 
 
Kajian ini melibatkan penilaian kualiti bahan mentah Orthosiphon stamineus, 
pemiawaian ekstrak yang berbeza, pembangunan nano-formulasi menggunakan ekstrak 
etanol maserasi dan penilaian aktiviti biologi terpilih (antioksidan dan sitotoksisiti). Daun 
kering O. stamineus memenuhi sifat fizikokimia, logam berat dan had mikrob yang 
digunakan untuk kajian selanjutnya. Lima ekstrak yang berbeza iaitu metanol, metanol 
(50%), etanol, etanol (50%) dan air diperolehi dengan menggunakan tiga teknik yang 
berbeza (Soxhlet, refluk dan maserasi). Analisis spektroskopi (FTIR dan UV) dan 
kromatografi (HPLC) telah dijalankan untuk pemiawaian ekstrak mentah. Keputusan 
menunjukkan flavonoid dan asid fenolik adalah bahan kimia utama dalam ekstrak O. 
stamineus. Kaedah RP-HPLC/DAD yang lebih baik telah disahkan untuk analisis 
kuantitatif asid rosmarinik (RA), 3-hidroksi-5, 6, 7, 4-metoksiflavon (TMF), sinensetin 
(SIN) dan eupatorin (EUP) dalam ekstrak mentah. Kaedah ini digunakan dalam kajian 
farmakokinetik dan kestabilan dalam ekstrak dan ekstrak yang diformulasi. Pengesahan 
kaedah RP-HPLC/DAD termasuk kekhususan, kelinearan (R2 ≥ 0.999), kepersisan (intra- 
dan antara hari) dan perolehan (90.2-104%). LOD dan LOQ sebatian yang dipilih masing-
masing adalah dalam julat 0.17 ± 0.01 hingga 0.24 ± 0.03 μg/mL dan 0.53 ± 0.03 hingga 
0.73 ± 0.09 μg/mL. Cap jari FTIR dan data HPLC dianalisis menggunakan alat 
kemometrik (PCA dan HCA) untuk kandungan metabolit (primer dan sekunder) dan 
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aktiviti terpilih. Perubahan dalam peratusan metabolit ini (flavonoid, fenolik, polisakarida, 
protein dan glikosaponin) dalam setiap ekstrak telah ditentukan. Ekstrak etanol termaserat 
telah dibangunkan dengan lebih lanjut menggunakan pelbagai polimer menggunakan 
serakan pepejal bagi meningkatkan keterlarutan dan bioperolehan oral dari flavonoid dan 
asid fenolik dalam ekstrak tersebut. Penyebaran pepejal yang dioptimumkan dianalisis 
menggunakan HPLC dan dicirikan dengan menggunakan kaedah cap jari FTIR dan 
kaedah fizikokimia (saiz zarah, potensi zeta, TEM dan SEM). Kesan pH pada kestabilan 
dan keterlarutan dalam penimbal dan air, pembebasan in-vitro, analisis metabolit total, 
dan aktiviti biologinya menunjukkan bahawa rumusan nano ekstrak etanol (ESD) yang 
menggunakan polimer (PVP/P407) dengan nisbah ekstrak kepada polimer (1.0: 1.1: 0.3) 
meningkatkan kandungan flavonoid (TMF = 3.56 ± 0.01% w/w, SIN = 2.46 ± 0.01% w/w 
dan EUP = 7.87 ± 0.01% w/w) dan RA (20.66 ± 0.01% w/w) berbanding ekstrak etanol 
(P <0.0001) dengan saiz zarah kurang daripada 200 nm. Berdasarkan kajian kestabilan 
dipercepatkan pada tiga keadaan penyimpanan (30, 40 dan 60 °C), jangka hayat RA, TMF, 
SIN dan EUP dalam ESD meningkat dengan signifikan (P <0.001) berbanding ekstrak 
etanol pada suhu di bawah 30 °C. Farrmakokinetik dan bioperolehan oral ESD dan ekstrak 
etanol yang dilakukan pada tikus Sprague-Dawley (SD) menunjukkan peningkatan 
signifikan (P <0.05) sebatian penanda (RA = 15.12 ± 0.92%, TMF = 29.82 ± 3.31% SIN 
= 38.76 ± 4.03% dan EUP = 34.60 ± 3.74%). Kajian ini memberikan maklumat mengenai 
penilaian kualiti bahan mentah dan ekstrak O. stamineus dan kejayaan pembangunan 
penyebaran pepejal etanol (ESD) menggunakan PVP/P407 bagi meningkatkan 
keterlarutan, kestabilan dan bioperolehan oral bagi flavonoid serta sebatian lain. 
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DEVELOPMENT OF NANO-FORMULATION USING PVP/P407 BASED ON 
SOLID DISPERSION FROM STANDARDISED ETHANOLIC EXTRACT OF 
ORTHOSIPHON STAMINEUS LEAF FOR SOLUBILITY AND ORAL 
BIOAVAILABILITY IMPROVEMENTS 
 
ABSTRACT 
 
This study involved the quality assessment of Orthosiphon stamineus raw 
materials, standardisation of different extracts, development of nano-formulation using 
macerated ethanolic extract and evaluated for selected biological activities (antioxidant 
and cytotoxicity). The dried leaves of O. stamineus fulfilled the physicochemical 
properties, heavy metals and microbial limits to be used for further study. Five different 
extracts namely methanolic, methanolic (50%), ethanolic, ethanolic (50%) and water were 
obtained using three different techniques (Soxhlet, reflux and maceration). The 
spectroscopic (FTIR and UV) and chromatographic (HPLC) analysis were carried out for 
standardisation of the crude extracts. The results revealed the flavonoids and phenolic 
acids were the major chemical constituents in O. stamineus extracts. An improved RP-
HPLC/DAD method was validated for the quantitative analysis of rosmarinic acid (RA), 
3-hydroxy-5, 6, 7, 4-methoxyflavone (TMF), sinensetin (SIN) and eupatorin (EUP) in the 
crude extracts. This method was applied in the pharmacokinetic and stability studies in 
the extract and formulated extract. RP-HPLC/DAD method validation including 
specificity, linearity (R2 ≥ 0.999), precision (intra- and inter-day) and recoveries (90.2-
104%). The LOD and LOQ of this selected compounds were in the range of 0.17 ± 0.01 
to 0.24 ± 0.03 μg/mL and 0.53 ± 0.03 to 0.73 ± 0.09 μg/mL, respectively. The FTIR 
fingerprint and HPLC data set were analysed using chemometric tools (PCA and HCA) 
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for its metabolite contents (primary and secondary) and selected activities. The variation 
in the percentage of these metabolites (flavonoids, phenolics, polysaccharides, proteins 
and glycosaponins) in each extract was determined. The macerated ethanolic extract was 
further developed using various polymers for solid dispersion to enhance solubility and 
oral bioavailability of the flavonoids and phenolic acids in the extract. The optimised solid 
dispersion was analysed using HPLC and was further characterised using on FTIR 
fingerprints and physicochemical methods (particles size, zeta potential, TEM and SEM). 
The effect of pH on stability and solubility in buffer and water, in-vitro release, total 
metabolite analysis, and its biological activities indicated that the nano-formulation of the 
macerated ethanolic extract (ESD) using polymers (PVP/P407) with a ratio of extract to 
polymers (1.0:1.1:0.3) enhanced the flavonoids contents  (TMF=3.56 ± 0.01% w/w, 
SIN=2.46 ± 0.01% w/w and EUP=7.87 ± 0.01% w/w) and RA (20.66 ± 0.01% w/w) 
compared to the ethanolic extract  (P <0.0001) with particles size less than 200 nm. Based 
on accelerated stability study at three storage conditions (30, 40 and 60°C), the shelf life 
of RA, TMF, SIN and EUP in ESD was significantly enhanced (P <0.001) compared to 
the ethanolic extract at temperature below 30 °C. The pharmacokinetic and oral 
bioavailability of ESD and ethanolic extract performed on Sprague-Dawley (SD) rat 
indicated significant enhancement (P <0.05) of mean absolute oral bioavailability of 
marker compounds (RA= 15.12 ± 0.92%, TMF= 29.82 ± 3.31%, SIN= 38.76 ± 4.03% and 
EUP= 34.60 ± 3.74%). The present study provides information on the quality assessment 
of O. stamineus raw and extract materials and the successful development of ethanolic 
solid dispersion (ESD) using PVP/P407 that enhanced the solubility, stability and oral 
bioavailability of flavonoids as well as other compounds. 
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CHAPTER 1 INTRODUCTION 
 
1.1 Background of study  
Orthosiphon stamineus Benth. (Cat’s Whiskers) is one of the popular medicinal 
plants in Southeast Asia particularly in Malaysia, Indonesia and Thailand. It is 
popularly consumed as herbal tea for the general health and to treat a wide range of 
diseases related to kidney and urinary disorders, diabetes, high blood pressure and 
bone or muscular pain (Adam et al., 2009; Indariani et al., 2014; Sumaryono et al., 
1991; Tezuka et al., 2000). Three types of phytochemicals were identified in various 
extracts of O. stamineus including polymethoxylated flavonoids (Akowuah et al, 2004; 
Lyckander & Maltreud, 1996), phenylpropanoids (caffeic acid derivatives) (Olah et 
al., 2007; Olah et al., 2003) and terpenoids (diterpenes and triterpenes) (Masuda et al., 
1992; Masuda et al., 1992a, 1992b). Among these compounds, 3'-hydroxy-5, 6, 7, 4’-
tetramethoxyflavone (TMF), sinensetin (SIN) eupatorin (EUP) and caffeic acid 
derivatives (rosmarinic acid) were found to possess potential therapeutic properties, as 
they were shown to exert antioxidant properties (Akowuah et al., 2005; Akowuah et 
al., 2004), diuretic and uricosuric actions in rats (Olah et al., 2003) and anticancer 
properties (Movahedi et al., 2015). Moreover, SIN and EUP were reported to have 
anti-inflammatory properties (Yam et al., 2010) and SIN has been reported to reverse 
the P- glycoprotein-mediated multidrug resistance in the absorption of drugs (Choi et 
al., 2002). Eupatorin has been reported to have antiproliferative activity against 
selective cancer cell lines, but it has no cytostatic effects in normal human cell line 
(Androutsopoulo et al., 2008; Dolečková et al., 2012; Tezuka et al., 2000).
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Studies have been performed to identify and quantify the phytochemical 
contents in O. stamineus extracts particularly using high performance liquid 
chromatography (HPLC) (Akowuah et al., 2004; Loon et al., 2005; Siddiqui & Ismail, 
2011; Yam et al., 2012). However, very few methods can detect simultaneously four 
markers (RA, TMF, SIN and EUP) (Akowuah et al., 2005; Akowuah et al., 2004) and 
most of it suffered from drawbacks including time consuming for HPLC separation 
used of buffer solution which may deteriorate efficiency of column and used of 
unsuitable solvent system. There is a great need for a faster, reliable and reproducible 
method for routine standardisation work of O. stamineus extract, raw material and 
commercial products for quality assessment of this herb. Despite the growing interest 
in these flavonoids in O. stamineus concerning of their routine standardisation work, 
there is a paucity of information regarding to their solubility, dissolution rate, stability 
and bioavailability of these compounds. Previous study was reported that the oral 
bioavailability of three lipophilic flavonoids (TMF, SIN and EUP) in O. stamineus 
extract was very poor and incomplete absorption, hence, it limited the therapeutic 
properties of O. stamineus (Loon et al., 2005). To overcome the issues,  there are many 
formulation strategies including nanoparticles, liposomes, complex with 
phospholipids, cyclodextrins and solid dispersions which appear to provide longer 
circulation, better permeability, and resistance to metabolic processes (Anand et al., 
2007; Hou et al., 2013; Kaur & Kaur, 2014). Among these approaches, solid dispersion 
is the most promising method due to the ease of preparation, ease of optimization and 
reproducibility of the manufacturing method (Chiou & Riegelmant, 1971). In 
comparison with other techniques, solid dispersion has shown many important 
advantages to become one of the most promising strategies for solubility enhancement 
including reduction of particle size to molecular level, reduce the agglomeration of 
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drug particles in the formulation, enhancing wettability and porosity, as well as 
changing drug crystalline state to amorphous which leads to faster dissolution for in 
vivo study (Vo et al., 2013). Another crucial aspect that can reduce the potency of 
herbal product is the stability of the phytonutrients which can be oxidised due to 
exposure to heat and moisture. Product shelf-life can be improved by altering the 
product formulation and enhancing the primary andsecondary packaging. Product 
formulation can be improved by adding preservatives, altering the biophysical nature 
of the active pharmaceutical ingredient or adding carrier molecules such as whey 
protein and maltodextrin via spray drying technique (Pang et al., 2014).  
 
In the present study, this work has been carried out with the aim to establish 
the quality assessment of O. stamineus raw materials and to perform and improve the 
standardisation of O. stamineus raw materials, extracts and nano-formulated extract 
using HPLC technique with reference to RA, SIN, TMF and EUP as marker 
compounds before undertaking any study. The fingerprint of O. stamineus extracts was 
further analysed using spectroscopic technique combined with principle component 
analysis (PCA and HCA) and analysis of primary and secondary metabolites were also 
evaluated. Next, this work focused on solid dispersion of standardised macerated 
ethanolic extract prepared in a variety of polymers (PVP, P407 and P188) via solvent 
evaporation method for the enhancement of its solubility and dissolution rate. The 
optimized formulation was further analysed for solubility, physicochemical properties, 
stability under various pH conditions, and analysis of primary and secondary 
metabolites along with HPLC and FTIR profiles, morphologies, in-vitro release, 
antioxidant and anticancer properties. The nano-formulation ethanolic solid dispersion 
(ESD) was further evaluated to determine the enhancement of oral bioavailability of 
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lipophilic flavonoids (TMF, SIN and EUP) and RA in rat plasma. A comparison of 
accelerated stability study has been performed for the  ethanolic extract and nano-
formulated ESD to determine the shelf life of marker compounds (RA, TMF, SIN and 
EUP). 
 
1.2 Problem statements 
Orthosiphon stamineus leaves has been selected throughout the study due to 
its pharmacological properties as antioxidant, diuretic and anticancer activities. It is 
popularly consumed as herbal tea either in sachet form or as a raw leaves. There are a 
number of products derived from O. stamineus leaves available in the market. 
However, many products are not registered with regulatory such as National 
Pharmaceutical Regulatory Agency (NPRA). Moreover, the herbal industries are still 
lacking or do not adhere to the quality assessment and standardisation guidelines due 
to the inadequancy of knowledge, financial support and modern technologies. The 
quality assessment and standardisation of herbal product are necessary to ensure the 
quality, efficacy and safety of the finish product. In addition, it also can ensure the 
reproducibility of raw materials that produces a high quality of herbal products.  
 
Despite the growing interest in these flavonoids in O. stamineus leaves 
concerning of their routine standardisation work, there is a lack of information 
regarding solubility, dissolution rate, stability and oral bioavailability of these 
compounds. So, in order to overcome these problems, present work was focused on 
the development of nano-formulation of standardised ethanolic extract (macerated) 
using solid dispersion via solvent evaporation method to enhance the solubility and 
oral bioavailability of lipophilic flavonoids. In addition, the current study conducted 
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and performed the pharmacokinetic and oral bioavailability of ethanolic extract and 
nano-formulated ESD using intravenous and oral absorption with reference to RA, 
SIN, TMF and EUP as marker compounds. 
 
Another problem with O. stamineus extracts which will limit its therapeutic 
properties was the stability of extract and it products with reference to marker 
compounds (RA, TMF, SIN and EUP). The ethanolic extract specifically is highly 
hygroscopic in nature. Therefore, the physical appearance, texture and colour get 
easily oxidised and the chemical components particularly the bioactive markers such 
as rosmarinic acid and eupatorin degraded overtime. So, with the help of encapsulation 
process of macerated ethanolic extract with selected polymers, the present study 
provides the analysis of accelerated stability of  ethanolic extract and it nano-
formulated ethanolic extract (ESD) with reference to RA, SIN, TMF and EUP in order 
to compare the quantity, quality and shelf life of marker compounds in both samples 
under variable conditions (elevated temperatures).  
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1.3 Significance of study 
From this study, all the information gathered can contribute to the knowledge 
and give better understanding especially to researchers, farmers, manufacturer as well 
as consumers on the importance of quality assessment of herbs in order to produce a 
high quality and reproducibility of batch to batch of raw materials as well as to produce 
a high value extract. This study also showed a development of new formulation using 
water-soluble co-polymers (PVP/P407) via solid dispersion technique that can 
enhance the solubility, stability and oral bioavailability of bioactive compounds (RA, 
TMF, SIN and EUP) as well as improved delivery of the O. stamineus pharmacological 
properties. 
 
1.4 General objectives 
Present study focused on the quality assessment of O. stamineus leaves 
following Malaysian Herbal Monograph (MHM) as guidelines.  O. stamineus leaves 
were extracted using different solvents; methanol, ethanol and water via three 
extraction methods including maceration, Soxhlet and reflux. The extracts were 
standardised based on the selected markers (RA, TMF, SIN and EUP) using HPLC 
analysis. The fingerprint analysis was done using FTIR and combined with 
chemometric tools (PCA and HCA). Furthermore, the extracts were analysed for the 
selected primary and secondary metabolites as well as the antioxidant and cytotoxic 
activities. Moreover, the selected extract (macerated ethanolic extract) was further 
prepared for the new nano-formulation in order to enhance the solubility and oral 
bioavailability of the lipophilic flavonoids (TMF, SIN and EUP) and RA with 
therapeutic effects. In addition, the stability of nano-formulated ESD was also 
7 
 
  
performed using accelerated stability study in order to determine the shelf life of the 
nano-formulated ESD based on the marker compounds.  
 
1.5 Specific objectives of the study 
The objectives of present study are as follows: 
1. To improve analytical method using chromatographic and spectroscopic  
            analysis for standardisation of O. stamineus leaves extracts based on selected    
            marker compounds.  
2. To develop and optimised nano-formulation of standardised ethanolic extract  
            using PVP/P407 via solid dispersion method based on aqueous solubility  
            enhancement of the selected marker compounds. 
3. To evaluate the physicochemical properties, in-vitro activities and comparison  
            study of accelerated stability of nano-formulated ESD and ethanolic extact. 
4. To determine the pharmacokinetic profile (in-vivo) of the nano-formulated  
            ESD and  ethanolic extract. 
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1.6 Summary of research work 
The summary of present work is summarized in Figure 1.1. The overall 
methodology consists of many steps, which includes procurement of O. stamineus 
leaves, quality assessment following Malaysian Herbal Monongraph (Monograph 
committee, 2009) using gravimetric analysis, extractive value, heavy metals and 
microbial limit test. The O. stamineus leaves were extracted by three different methods 
(maceration, reflux and Soxhlet) using methanol, methanol (50%), ethanol, ethanol 
(50%) and water. All extracts were standardised using different spectroscopic and 
chromatographic techniques (UV-Vis, FT-IR, FT-NIR, HPTLC and HPLC). 
Moreover, the contents of total metabolites (primary and secondary) and it biological 
activities (antioxidant and cytotoxicity) were also quantified in the extracts. The best 
standardised extract (macerated ethanolic extract) was selected for further 
development of nano-formulated solid dispersion using selected polymers in order to 
improve the solubility, stability and oral bioavailability of the selected constituents 
with it therapeutic properties. The optimised solid dispersion was further characterised 
for it physicochemical properties, stability under various pH conditions, analysis of 
total metabolites along with HPLC and FTIR profiles, morphologies, in-vitro release, 
stability of prepared nano-formulation and pharmacokinetic study. 
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Figure 1.1 Flow chart of research work 
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CHAPTER 2 LITERATURE REVIEW 
 
2.1 Orthosiphon stamineus Benth. 
Orthosiphon stamineus Benth is one of the valuable medicinal plants in 
Lamiaceae family due to its therapeutic effects. Synonym names of O. stamineus were 
known as O. aristatus, O. spiralis (Lour) Merr., O. aristatum Blume Bijdr., 
Clerodendranthus spicatum (Thunb.), C. stamineus (Bentham) Kudo and 
Clerodendrum spicatus Thunberg (Merrill, 1935). In Malaysia, it is known as ‘misai 
kucing’ due to the uniqueness of its flower resembling a cat’s whiskers. Other 
vernacular names were given to this herb including Java tea (English), Remujung and 
Kumis kucing (Indonesia), Balbas-pusa (Phillipines) and Yaa nuat maeo (Thailand) 
(Himani et al., 2013). In Malaysia, there are two varieties that have been identified 
based on the colour of the flowers; white and purple flowers. These varieties can be 
differentiated based on the colour of the corolla and calyx and the leaves characteristics 
where the leaves of the purple flower are broader and shorter than the white flower 
(Chan & Loo, 2006).  
 
 Plant description 
O. stamineus Benth (Lamiaceae) or locally known as ‘misai kucing’ in 
Malaysia is a herbaceous shrub which can grow up to a height of 1-1.5 m (Figure 2.1). 
This herb originated from Southeast Asia countries including Malaysia, Indonesia, 
Thailand, Vietnam and neighbouring countries (Truong et al., 2010). Two different 
varieties were found in Malaysia based on the colour of the flower; purple and white 
colours. Both varieties produced petioles of dark green leaves. The leaves were placed 
opposite to each other on the stem. However, there were differences on the leaves for 
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both varieties. The purple variety has shorter and broader leaves than the white variety. 
The white variety produces a rhomboid shape with acuminate apex, obtuse based 
leaves without coloured spot. The stem morphology for both varieties are similar 
except the colour of the stem where the white variety has green stem while the purple 
variety has greenish maroon colour stem. With respect to the morphology of flower, 
there are differences in term of colour and size of corolla and calyx. The purple variety 
produces light purple colour at the lobes of the white corolla while white variety 
produced totally white colour without having purple colour at the edge. The calyx 
colour is also different between two varieties where the purple variety produces 
maroon colour calyx while the white variety produces green calyx. In terms of size of 
the corolla and calyx, there were also differences between both varieties where the 
white variety has a longer corolla and calyx tubes compared to the purple variety. The 
seed of both varieties is oval in shape with hard and rough surface testa and each fruit 
produces four seeds. The colour of the fruit after maturityis also different where the 
purple variety produces purplish red fruits while the white variety produces greenish 
red in colour (Chan & Loo, 2006).  
 
12 
 
  
 
Figure 2.1 Picture of O. stamineus Benth. (a) whole plant (b) flower 
 
 
 Traditional uses of O. stamineus 
O. stamineus can be found in South East Asian countries especially in 
Malaysia, Indonesia, Thailand, Vietnam and Myanmar. This herb is popular and 
recognized in European countries including England, Holland and France as a herbal 
product (Adnyana et al., 2013) and it is also called as “Java tea”. Traditionally, O. 
stamineus leaves has been used for treating a range of diseases such as a remedy for 
kidney stones and nephritis, edema, inflammation, urinary, lithiasis, hepatitis, 
rheumatism, eruptive fever, diabetes, influenza, jaundice, pain in the bladder with 
frequent urination, diuretic, biliary and hypertension (Awale et al., 2001; Dat et al., 
1992; Goh et al., 1995; Tezuka et al., 2000).  
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 Phytochemicals review of O. stamineus 
O. stamineus contains important class of compounds including polyphenols 
(lipophilic flavonoids and phenolic acids), terpenoids (diterpenes and triterpenes), 
sterols and essential oils. Polyphenols are very important due to its antioxidant 
properties and prevention of various diseases associated with cancer, cardiovascular 
and neurodegenerative diseases (Manach et al., 2004). Polyphenols are naturally 
occurring in vegetables, fruits, beverages and cereals. It influences the taste of food 
including bitterness, colour, flavour, astringency, odour and oxidative stability 
(Pandey & Rizvi, 2009). So, due to the increasing demand of polyphenols consumption 
nowadays, the research on O. stamineus has also increased in many aspects including 
chemical constituents as well as biological activities. The phytochemicals study of O. 
stamineus has been conducted since 1930’s (Tezuka et al., 2000). Extensive study on 
chemical compounds in different parts of O. stamineus was reported previously and 
summarized in Table 2.1. Among the reported compounds, polymethoxylated 
flavonoids such as sinensetin and eupatorin and caffeic acid derivatives, which include 
rosmarinic acid, cichoric acid, and caffeic acid were the most important components 
of O. stamineus leaves (Olah et al., 2003).
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Table 2.1 Chemicals constituents in different parts of O. stamineus 
 
Compounds Class of compounds Locality Part of plants Extracts References 
Methylripariochromene A Benzopyrene Indonesia Leaves 
Chloroform and 
water fractions from 
water extract 
(Matsubara et al., 1999) 
Orthosiphol A & B  Oxygenated pimarane diterpenes Myanmar Leaves  (Masuda et al., 1992) 
Orthosiphol C Diterpene Taiwan Aerial Methanol extract (Nguyen et al., 2004) 
Orthosiphol D & E Diterpene Japan Aerial Ethanol fraction of 
methanol extract 
(Takeda et al., 1993) 
Japan Aerial Methanol extract (Awale et al., 2002a) 
Orthosiphol F-J Diterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Orthosiphol K-N Diterpene Myanmar Aerial Methanol extract (Awale et al., 2001) 
Indonesia Aerial Methanol extract (Awale et al., 2003) 
Orthosiphol O Diterpene Taiwan Aerial Methanol extract (Nguyen et al., 2004) 
Orthosiphol P & Q Diterpene Myanmar Aerial Methanol extract (Awale et al., 2001) 
Orthosiphol R-T Diterpene Japan Aerial Methanol extract (Awale et al., 2002a) 
Orthosiphol U-Z Diterpene Indonesia Aerial Methanol extract (Awale et al., 2003) 
Orthosiphonone A-D Isopimarane diterpene Indonesia Aerial Methanol extract (Awale et al., 2003) 
Hexanal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans-2-Hexanal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
cis-3-Hexen-l-ol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Hexan-1-ol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
4-Heptenal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
15 
   
Table 2.1 Cont. 
Heptenal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Benzaldehyde monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
α-Pinene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Camphene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
l-Octen-3-ol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Pinene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
3-Octanol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
2-Pentenyl furane monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
2-Amylfurane monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
p-Cymene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
1,8-Cineol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Limonene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Acetophenone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
cis-2-Octenal monoterpene and sesquiterpene  
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
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Table 2.1 Cont. 
Phenylacetaldehyde monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans,cis-Octa-3,5-dien-
2-one 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
cis-Linalooloxide monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans,trans-Octa-3,5-
dien-2-one 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Linalool monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans-Linalooloxide monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Undecan monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
2,6,6-Trimethyl-2-
cyclohexe-l,4-dione 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Perillen monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Camphor monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
δ-Terpineol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans -2-(cis)-6-
Nonadienale 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Menthone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Isomenthone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Methylchavicol monoterpene and sesquiterpene  Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
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Table 2.1 Cont. 
Borneol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Decanal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Naphthalene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Dodecane monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Cittonellol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Carvone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Cyclocitral monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans-Anethol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Isobornylacetat monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Safranal monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
1-Methylnaphthalene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Bornyl acetate monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Tridecan monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
2-methylnaphthalene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
trans, trans-Deca-2,4-
dienal 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
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Table 2.1 Cont.  
γ-Elemene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
α-Cubebene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Damascenone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
α-Copaene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Bourbonene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Eugenol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Elemene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Methyleugenol monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
cis-Caryophyllene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Carryophyllene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Geranylacetone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
α-Humulene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
β-Ionone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Germacrene D monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
α-Muuiolene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
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Table 2.1 Cont. 
 
δ-Cadinene monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Germacrene B monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Dehydroionone monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Caryophyllene oxide monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Hexahydrofamesylaceto
ne 
monoterpene and sesquiterpene 
hydrocarbons 
Malaysia Leaves and stems essential oils (Hossain et al., 2008) 
Sinensetin Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Malaysia Leaves Methanol extract (Loon et al., 2005) 
Malaysia Leaves    Chloroform 
fraction 
(Yam et al., 2010) 
Romania Leaves    Ethanol-water extracts 
(50 and 70%) 
(Olah et al., 2003) 
    
Eupatorin Flavonoid Malaysia Leaves Methanol extract (Akowuah et al., 2004) 
  Malaysia Leaves Standardised extract (Loon et al., 2005) 
  Malaysia Leaves Chloroform fraction (Yam et al., 2010) 
      
3’hydroxy-5, 6, 7, 4’-
tetramethoxyflavone 
(TMF) 
Flavonoid Malaysia Leaves Methanol, 25-75%  
methanol extracts 
and water extracts 
(Siddiqui & Ismail, 
2011) 
  Malaysia Leaves Methanol extract (Akowuah et al., 2004) 
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Tetramethylscutellarein Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Salvigenin Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Ladanein Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
vomifoliol Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
5-hydroxy-6,7,3',4'-
tetra-methoxyflavone 
Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
7,3',4'-tri-O-
methylluteolin 
Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
6-hydroxy-5,7,4'-
trimethoxy-flavone 
Flavonoid Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Tetramethylether-
scutellarein 
Flavonoid East Asean Leaves Methanol extract (Lyckander & 
Maltreud, 1996) 
Caffeic acid Polyphenol Indonesia Leaves 50% methanol 
extract 
(Sumaryono et al., 
1991) 
Cichoric acid Polyphenol Romania Leaves Ethanol-water 
extracts (50 and 
70%) 
(Olah et al., 2003) 
Rosmarinic acid Polyphenol Malaysia Leaves Methanol extract (Akowuah et al., 2004) 
 
 Polyphenol Indonesia Leaves 50% methanol 
extract 
(Sumaryono et al., 
1991) 
  Malaysia Leaves Methanol, 25-75%  
methanol extracts 
and water extracts 
(Siddiqui & Ismail, 
2011) 
  Malaysia Leaves Methanol extract (Akowuah et al., 2004) 
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 Polyphenol Indonesia Leaves 50% methanol 
extract 
(Sumaryono et al., 
1991) 
  Malaysia Leaves Methanol, 25-75%  
methanol extracts 
and water extracts 
(Siddiqui & Ismail, 
2011) 
2,3-Dicaffeoyl-tartaric 
acid 
Polyphenol Indonesia Leaves  50% methanol    
  extract 
(Sumaryono et al., 
1991) 
Aurantiamide acetate Dipeptide Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Oleanolic acid Triterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Ursolic acid Triterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Betulinic acid                       Triterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Hydroxybetulinic acid                       Triterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Staminol A & B                       Diterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Staminols C & D                       Diterpene Indonesia Aerial Methanol extract (Stampoulis et al., 
1999) 
Secoorthosiphol A-C                       Diterpene Taiwan Aerial Methanol extract (Nguyen et al., 2004) 
  Japan Aerial Methanol extract (Awale et al., 2002b) 
Norstaminol A-C                       Diterpene Vietnam Aerial Methanol extract (Tezuka et al., 2000) 
Norstaminone A                       Diterpene Myanmar Aerial Methanol extract (Awale et al., 2003) 
Neoorthosiphone A                       Diterpene China Aerial Methanol extract (Awale et al., 2004) 
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 Quality assessment and standardisation of O. stamineus 
Due to increasing demand on the use of O. stamineus as food supplement and 
botanical products, the quality assessment and standardisation of this herb should be 
conducted to ensure the safety and efficacy of these products in the market. The 
process should be conducted at the first stage of cultivation to the production for 
clinical formulation. World Health Organization (WHO) established guidelines for 
good agricultural practice (GACP) for medicinal plants to ensure reproducible 
quality of herbal medicinal products (WHO, 2003; Yadav & Dixit, 2008). According 
to WHO, quality assessment and standardisation of herbal medicines is a process 
involved in the physicochemical properties of raw materials covering various aspects 
including micro and macroscopic examination for adulteration, foreign organic 
matter, ash values, moisture content, extractive values, crude fibre, qualitative and 
quantitative chemical evaluation, chromatographic examination and toxicology 
studies (pesticide residues, heavy metals and microbial limit test) (WHO, 1998). The 
process involved scientific investigations including physical, chemical and 
biological evaluations with the aim to ensure the quality, safety and efficacy of 
herbal products in the market. In this study, the quality assessment of O. stamineus 
raw leaves was evaluated following the standard in Malaysian Herbal Monograph 
(MHM) (Monograph committee, 2009) before undertaking this study. Moreover, the 
standardisation of different extracts was further analysed using new developed and 
validated method using RA, TMF, SIN and EUP as marker compounds. 
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 Pharmacological review of O. stamineus 
Many studies have been conducted in order to justify the traditional uses of O. 
stamineus. Some of studies were conducted in different extracts of O. stamineus and 
some in selected fractions and pure compounds (Adnyana et al., 2013). It was reported 
as good anti-oxidative (Awale et al., 2001), diuretic and nephroprotective (Arafat et al., 
2008; Awale et al., 2003a; Madhukar et al., 2010), anti-inflammatory (Ohashi et al., 
1999), anti-bacterial and antimicrobial (Tezuka et al., 2000), cytotoxic, anti-
proliferative and antiangiogenic (Adnyana et al., 2013), anti-hypertensive (Ohashi., 
2000;  Matsubara et al., 1999), antidiabetic (Indariani et al., 2014; Rao et al., 2014), 
anti-pyretic (Yam et al., 2009) and hepatoprotective (Chin et., 2009; Yam et al., 2007). 
The summary of the previous pharmacological studies of O. stamineusis shown in Table 
2.2. In present study, ten standardised extracts from three extraction techniques and 
nano-formulated extract of O. stamineus leaves were subjected to evaluation of their 
antioxidant and cytotoxic activities.  
 
Previous studies have analysed the antioxidant potential of O. stamineus. 
Akowuah et al., (2004) reported the antioxidant properties of methanolic extract of O. 
stamineus leaves from various locations. The evaluation of antioxidant properties was 
based on the in vitro β-carotene-linoleic acid system assay. In addition, the content of 
three flavonoids (sinensetin, eupatorin and 3'-hydroxy-5, 6, 7, 4’-tetramethoxyflavone) 
and a caffeic acid derivative (rosmarinic acid) were measured using a developed HPLC 
method. The results demonstrated significant variation in antioxidant activities related 
to variation for compounds. Therefore, it was concluded that presence of flavonoids and 
phenolic acids in O. stamineus extract are implicated to antioxidant activity. 
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Subsequently, study by Akowuah et al. (2005) reported the effect of different 
extraction solvents on free radical scavenging activity of leaves of O. stamineus using 
1, 1-diphenyl-2-picrylhydrazyl (DPPH) assay. All extracts showed significant free 
radical scavenging activity. In addition, contents of SIN, EUP, TMF and RA were 
analysed by HPLC method. The results demonstrated that free radical scavenging 
activity (DPPH assay) was poorly correlated with the concentration of the flavonoids 
and phenolics in extracts. Therefore, presence of other secondary metabolites and 
primary metabolites which may act as hydrogen donors in the plant materials might 
be responsible for this activity. Following years, Khamsah et al. (2006) reported the 
antioxidant activity of O. stamineus extracts might be due to presence of staminane-
type diterpenes and triterpenes. They were reported that, there is no simple 
relationship between the antioxidant activity of O. stamineus extracts with the level 
of total phenolics and flavonoids component presence in the extracts. In another study 
by Yam et al., (2016) reported the evaluation of the antioxidant activity of methanolic 
extract (50%) of O. stamineus leaves. Superoxide radical scavenging, hydroxyl 
radical scavenging, and ferrous ion chelating methods were used to evaluate the 
antioxidant properties of the extract. The results indicated that the respective extract 
showed good superoxide radical scavenging, hydroxyl radical scavenging, and ferrous 
ion chelating  
 
On 2010, Siddique et al., was reported the evaluation of primary metabolite 
contents (total proteins, total polysaccharides and glycosaponins), cytotoxicity and 
antiangiogenic activity of freeze dried and spray dried methanolic (50%) extract. The 
result showed freeze dried extract contain high content of proteins and glycosaponins 
while contents of polysaccharides were high in spray dried extracts. Concurrently, the 
